Manuela Federico

ORCID: 0009-0005-0241-5466
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Advanced Radiotherapy Techniques
  • Prostate Cancer Treatment and Research
  • Prostate Cancer Diagnosis and Treatment
  • Management of metastatic bone disease
  • Cancer Diagnosis and Treatment
  • Lung Cancer Research Studies
  • Bladder and Urothelial Cancer Treatments
  • Bone health and treatments
  • Lung Cancer Treatments and Mutations
  • Cancer Immunotherapy and Biomarkers
  • Neuroendocrine Tumor Research Advances
  • Head and Neck Cancer Studies
  • Glioma Diagnosis and Treatment
  • Lung Cancer Diagnosis and Treatment
  • Brain Metastases and Treatment
  • Renal cell carcinoma treatment
  • Medical Imaging Techniques and Applications
  • Oral health in cancer treatment
  • Radiopharmaceutical Chemistry and Applications
  • Cancer Genomics and Diagnostics
  • Spine and Intervertebral Disc Pathology

Abstract Aim Radiation-induced oral mucositis (RIOM) is the most frequent side effect in head and neck cancer (HNC) patients treated with curative radiotherapy (RT). A standardized strategy for preventing treating RIOM has not been defined. of this study was to perform a real-life survey on management among Italian RT centers. Methods 40-question administered 25 radiation oncologists working different centers across Italy. Results total 1554 HNC have participating 2021, majority (median 91%)...

10.1007/s00520-023-08185-5 article EN cc-by Supportive Care in Cancer 2023-12-19

The term “oligometastasis” represents a relatively novel idea, which denotes condition characterized by cancer dissemination with limited number of lesions (usually fewer than five). aim the present study is to report bibliometric analysis oligometastatic disease/state, incorporating all relevant studies on topic for more 20 years. research strategy included at least one terms “Oligmetastases”, “Oligometastasis”, “Oligometastatic”, “Oligoprogression, “Oligoprogressive”, “Oligorecurrent”, or...

10.3390/cancers15153902 article EN Cancers 2023-07-31

Background: The favorable role of SBRT for lymph-nodal oligometastases from prostate cancer has been reported by several retrospective and prospective experiences, suggesting a more indolent natural history disease when compared to patients with bone oligometastases. This multicenter study evaluates the outcomes cohort treated stereotactic body radiotherapy Methods: Inclusion criteria were up five detected either Choline-PET or PSMA-PET in naïve ADT already ongoing systemic therapy at least...

10.3390/medicina59081442 article EN cc-by Medicina 2023-08-09

Background/Aim: This study aimed to assess whether the patient's abdominal adiposity affects performance of Exactrac imaging system compared cone beam computed tomography (CBCT)-based setup, which was used as reference positioning for image-guided radiotherapy (IGRT) delivery patients with localized prostate cancer. Patients and Methods: The daily positionings cancer undergoing definitive or adjuvant/salvage (RT) were analyzed. fat areas pelvic incidence angle determined on CT simulation...

10.21873/anticanres.16597 article EN Anticancer Research 2023-08-30

Background: This multicentric, retrospective study investigated the use of stereotactic body radiotherapy (SBRT) in patients (pts) with metastatic renal cell carcinoma (mRCC) who experienced oligoprogression during a combination therapy an immune checkpoint inhibitor (ICI) and tyrosine–kinase (TKI). Methods: We retrospectively evaluated 34 pts affected by oligoprogressive RCC treated ICI–TKI between January 2020 December 2023. SBRT was delivered to each site disease. After SBRT, were given...

10.3390/jpm14101030 article EN Journal of Personalized Medicine 2024-09-27
Coming Soon ...